HE outcomes showed that wild type mice after treatment with Ad-EDNRB adenoviral particles or EDNRB agonist IRL-1620 TFA presented serious liver pathologic injury such as more inflammatory infiltration, hepatocyte necrosis and edema (Fig. 6A). Here, EDNRB is linked to hereditary elliptocytosis.